XML 112 R60.htm IDEA: XBRL DOCUMENT v3.25.4
Equity Method Investments (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Jul. 31, 2019
Schedule Of Equity Method Investments [Line Items]        
Operating expenses $ 381,100,000 $ 513,600,000 $ 480,000,000.0  
Net loss (80,800,000) (198,900,000) (367,300,000)  
Loss from equity method investment 0 0 (2,500,000)  
Equity method investments 0      
Oerth        
Schedule Of Equity Method Investments [Line Items]        
Operating expenses 1,100,000 3,700,000 8,300,000  
Net loss $ (1,100,000) $ (3,700,000) $ (8,300,000)  
Oerth        
Schedule Of Equity Method Investments [Line Items]        
Ownership interest, percentage 42.90% 43.60% 45.00%  
Future grant of incentive units to service providers, percentage       15.00%
Loss from equity method investment $ 0 $ 0 $ (2,500,000)  
Equity method investments $ 0 $ 0    
Bayer LP | Oerth        
Schedule Of Equity Method Investments [Line Items]        
Equity interest       $ 56,000,000.0
Ownership interest, percentage       50.00%